Navigating the Post-Acquisition Landscape

UnitedHealth Group’s acquisition of Amedisys earlier this year triggered a ripple effect, requiring the divestiture of certain assets to satisfy regulatory requirements. BrightSpring emerged as a key player in acquiring a significant portion of these divested holdings, including assets originating from both Amedisys and LHC Group, which UnitedHealth acquired in 2023. While the majority of the assets stem from Amedisys, BrightSpring CEO Jon Rousseau clarified that the transaction now encompasses a larger, though still minority, share of former LHC Group branches as a result of ongoing negotiations with the Federal Trade Commission (FTC).

“We’ve just more or less said Amedisys in the past,” Rousseau stated during BrightSpring’s third-quarter earnings call. “It is a significant majority of those branches. As United was working through all of its final agreements with the FTC, the universe did increase a little bit… And we do expect that transaction to close in the quarter.”

BrightSpring’s Strategic Focus: Integrated Care and Growth

BrightSpring isn’t simply expanding its footprint; it’s strategically building an integrated healthcare ecosystem. The company provides a comprehensive suite of services, including pharmacy, home health, primary care, and behavioral health, serving over 460,000 individuals daily across all 50 states. This integrated approach is central to BrightSpring’s growth strategy, particularly in the burgeoning field of in-home primary care.

Rousseau emphasized the potential of at-home primary care, stating, “We believe primary care at home remains a large opportunity as we continue to build out the business, particularly as it relates to the benefits of our integrated services.” This sentiment is echoed by recent investment trends, with companies like Nest Health, which secured $12.5 million in August, and Gather Health, raising $21 million in July, demonstrating strong investor confidence in this sector.

BrightSpring’s growth strategy is two-pronged: core growth, focused on optimizing existing business segments, and strategic growth, centered on expanding primary care services and securing value-based contracts. The company’s third-quarter 2025 results reflect this approach, with home health average daily census increasing by 3% year-over-year to 29,592, and personal care census rising by 1% to 16,134.

Financially, BrightSpring reported Q3 revenues of $3,334 million, a 28.2% increase year-over-year. Provider revenue grew by 9%, with home health care contributing approximately 50% of that revenue. The home health segment itself experienced a 12% revenue increase, reaching $188 million, driven by strong quality metrics, patient satisfaction, operational investments, and preferred provider contracts with Medicare Advantage plans.

Did You Know? The home healthcare market is projected to experience substantial growth in the coming years, fueled by an aging population and a growing preference for receiving care in the comfort of one’s own home.

But what does this level of consolidation mean for patients seeking home healthcare services? Will it lead to improved care coordination and access, or will it create challenges in navigating a more complex system?

Furthermore, how will BrightSpring leverage its integrated service model to differentiate itself in a competitive market and deliver superior patient outcomes?

BrightSpring anticipates the asset acquisition to be accretive starting in 2026, signaling a long-term commitment to growth and innovation in the home healthcare sector. The company’s focus on integrated care, coupled with strategic acquisitions, positions it as a significant force in shaping the future of healthcare delivery.

Frequently Asked Questions About BrightSpring’s Acquisition